ZA200603126B - Pharmaceutical compositions for therapeutic use - Google Patents
Pharmaceutical compositions for therapeutic useInfo
- Publication number
- ZA200603126B ZA200603126B ZA200603126A ZA200603126A ZA200603126B ZA 200603126 B ZA200603126 B ZA 200603126B ZA 200603126 A ZA200603126 A ZA 200603126A ZA 200603126 A ZA200603126 A ZA 200603126A ZA 200603126 B ZA200603126 B ZA 200603126B
- Authority
- ZA
- South Africa
- Prior art keywords
- pharmaceutical compositions
- therapeutic use
- therapeutic
- pharmaceutical
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
- A61K39/292—Serum hepatitis virus, hepatitis B virus, e.g. Australia antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/543—Mucosal route intranasal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2730/00—Reverse transcribing DNA viruses
- C12N2730/00011—Details
- C12N2730/10011—Hepadnaviridae
- C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
- C12N2730/10134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Oncology (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU20030240A CU23405A1 (es) | 2003-10-20 | 2003-10-20 | Composiciones farmacéuticas para uso terapéutico |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200603126B true ZA200603126B (en) | 2007-02-28 |
Family
ID=34441708
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200603126A ZA200603126B (en) | 2003-10-20 | 2006-04-19 | Pharmaceutical compositions for therapeutic use |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20070275012A1 (de) |
| EP (1) | EP1676587A1 (de) |
| JP (1) | JP2007509081A (de) |
| KR (1) | KR20060117920A (de) |
| CN (1) | CN1882359A (de) |
| AR (1) | AR046063A1 (de) |
| AU (1) | AU2004281098B2 (de) |
| BR (1) | BRPI0415654A (de) |
| CA (1) | CA2542680A1 (de) |
| CU (1) | CU23405A1 (de) |
| MX (1) | MXPA06004387A (de) |
| RU (1) | RU2362586C2 (de) |
| WO (1) | WO2005037311A1 (de) |
| ZA (1) | ZA200603126B (de) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU23740A1 (es) * | 2009-09-29 | 2011-12-28 | Ct Ingenieria Genetica Biotech | Método de obtención de una formulación de antígenos del virus de la hepatitis b |
| BR112020005695A2 (pt) | 2017-10-05 | 2020-10-06 | Toko Yakuhin Kogyo Co., Ltd. | composição da vacina da hepatite b nasal e método para produzir a mesma |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU22290A1 (es) * | 1990-10-08 | 1995-01-31 | Cigb | Procedimiento para la obtencion de antigeno de superficie del virus de la hepatitis b de superior capacidad inmunoganica y su uso en un preparado vacunal |
| DK1053018T3 (da) * | 1998-02-03 | 2005-08-15 | Yissum Res Dev Co | Administration af immunogene molekyler via HBsAg-partikler |
| CU22871A1 (es) * | 1998-12-02 | 2003-10-21 | Ct Ingenieria Genetica Biotech | Formulaciones conteniendo partículas semejantes a virus como inmunopotenciadores por vía mucosal |
| CU23002A1 (es) * | 2000-12-01 | 2004-11-18 | Ct Ingenieria Genetica Biotech | Método de obtención de agregados antigénicos y su uso en formulaciones |
| CU23031A1 (es) * | 2002-01-24 | 2005-02-23 | Ct Ingenieria Genetica Biotech | Antigeno de superficie del virus de la hepatitis b como inmunopotenciador mucosal, formulaciones resultantes |
-
2003
- 2003-10-20 CU CU20030240A patent/CU23405A1/es unknown
-
2004
- 2004-10-08 AR ARP040103654A patent/AR046063A1/es unknown
- 2004-10-20 RU RU2006117308/15A patent/RU2362586C2/ru active
- 2004-10-20 BR BRPI0415654-4A patent/BRPI0415654A/pt not_active IP Right Cessation
- 2004-10-20 KR KR1020067008110A patent/KR20060117920A/ko not_active Application Discontinuation
- 2004-10-20 WO PCT/CU2004/000011 patent/WO2005037311A1/es active Application Filing
- 2004-10-20 EP EP04762299A patent/EP1676587A1/de not_active Withdrawn
- 2004-10-20 AU AU2004281098A patent/AU2004281098B2/en not_active Ceased
- 2004-10-20 US US10/576,158 patent/US20070275012A1/en not_active Abandoned
- 2004-10-20 JP JP2006535932A patent/JP2007509081A/ja active Pending
- 2004-10-20 CA CA002542680A patent/CA2542680A1/en not_active Abandoned
- 2004-10-20 CN CNA2004800341532A patent/CN1882359A/zh active Pending
- 2004-10-20 MX MXPA06004387A patent/MXPA06004387A/es unknown
-
2006
- 2006-04-19 ZA ZA200603126A patent/ZA200603126B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| RU2362586C2 (ru) | 2009-07-27 |
| CU23405A1 (es) | 2009-08-04 |
| EP1676587A1 (de) | 2006-07-05 |
| MXPA06004387A (es) | 2006-06-14 |
| KR20060117920A (ko) | 2006-11-17 |
| CN1882359A (zh) | 2006-12-20 |
| AU2004281098A1 (en) | 2005-04-28 |
| US20070275012A1 (en) | 2007-11-29 |
| JP2007509081A (ja) | 2007-04-12 |
| WO2005037311A1 (es) | 2005-04-28 |
| CA2542680A1 (en) | 2005-04-28 |
| AU2004281098B2 (en) | 2009-06-25 |
| AR046063A1 (es) | 2005-11-23 |
| RU2006117308A (ru) | 2007-12-10 |
| BRPI0415654A (pt) | 2006-12-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB0320382D0 (en) | Pharmaceutical compositions | |
| GB0327723D0 (en) | Pharmaceutical compositions | |
| IL172824A0 (en) | Pharmaceutical formulations | |
| EP1603543A4 (de) | Therapeutische zusammensetzungen | |
| GB0302671D0 (en) | Pharmaceutical formulations | |
| GB2394894B (en) | New use for pharmaceutical composition | |
| ZA200605080B (en) | Pharmaceutical compositions | |
| HU0301154D0 (en) | Pharmaceutical composition | |
| GB0300427D0 (en) | Pharmaceutical composition | |
| GB0300531D0 (en) | Pharmaceutical compositions | |
| EP1608385A4 (de) | Therapeutische zusammensetzungen | |
| EP1648411A4 (de) | Pharmazeutische zusammensetzungen | |
| GB0307866D0 (en) | Pharmaceutical composition | |
| EP1699458A4 (de) | Pharmazeutische zusammensetzung | |
| GB0329232D0 (en) | Pharmaceutical composition | |
| GB0317663D0 (en) | Pharmaceutical composition | |
| GB0302672D0 (en) | Pharmaceutical formulations | |
| GB2392618B (en) | Compositions for therapeutic use | |
| GB0300885D0 (en) | Pharmaceutical composition | |
| EP1655029A4 (de) | Medizinische zusammensetzungen | |
| GB0316341D0 (en) | Pharmaceutical formulations | |
| EP1600445A4 (de) | Medizinische zusammensetzung | |
| GB0306933D0 (en) | Pharmaceutical composition | |
| ZA200603126B (en) | Pharmaceutical compositions for therapeutic use | |
| GB0307869D0 (en) | Pharmaceutical composition |